Matthew Stoll

Title: Innovations by Matthew Stoll in Cerebrospinal Fluid Treatment

Introduction

Matthew Stoll is an innovative inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical technology, particularly in the treatment of cerebrospinal fluid (CSF). His work focuses on developing systems and methods that enhance the conditioning of biologic fluids.

Latest Patents

Matthew Stoll holds a patent for "Systems and methods for the conditioning of cerebrospinal fluid." This patent describes various methods for treating biologic fluids, specifically CSF. The disclosed embodiments may include filtering CSF from a human or animal subject, heating or cooling CSF to target temperatures, applying light treatment, separating cells based on their dielectric properties, and introducing additives to target particles. The method involves withdrawing fluid containing CSF, treating it, and returning a portion of the treated fluid to the subject. During the operation of the system, parameters such as flow rate can be modified. He has 1 patent to his name.

Career Highlights

Matthew Stoll is currently employed at Minnetronix, Inc., where he continues to develop innovative solutions in the medical field. His work has the potential to significantly impact the treatment of various medical conditions related to cerebrospinal fluid.

Collaborations

Matthew collaborates with talented professionals in his field, including Blake A Hedstrom and Shivanand Lad. Their combined expertise contributes to the advancement of medical technologies.

Conclusion

Matthew Stoll's innovative work in the conditioning of cerebrospinal fluid showcases his commitment to improving medical treatments. His contributions are paving the way for advancements in the field of medical technology.